We are live on ! Find out more
OCUL icon

Ocular Therapeutix
OCUL

186 hedge funds and large institutions have $1.45B invested in Ocular Therapeutix in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 75 increasing their positions, 48 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

137% more call options, than puts

Call options by funds: $9.7M | Put options by funds: $4.1M

56% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 48

44% more capital invested

Capital invested by funds: $1.01B → $1.45B (+$447M)

12.21% more ownership

Funds ownership: 86.38% → 98.59% (+12%)

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

5% less funds holding

Funds holding: 196 → 186 (-10)

23% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 31

Holders
186
Holders Change
-10
Holders Change %
-5.1%
% of All Funds
2.45%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
24
Increased
75
Reduced
48
Closed
31
Calls
$9.7M
Puts
$4.1M
Net Calls
+$5.6M
Net Calls Change
+$2.62M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$146M
2
PBA
Paradigm Biocapital Advisors
New York
+$16.5M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$10.6M
4
Invesco
Invesco
Georgia
+$5.75M
5
UBS Group
UBS Group
Switzerland
+$4.93M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$11.5M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$10.3M
3
PA
Perceptive Advisors
New York
-$6.71M
4
ACA
Avoro Capital Advisors
New York
-$5.17M
5
SCM
Silverarc Capital Management
Massachusetts
-$4.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
PFBT
176
Parkside Financial Bank & Trust
Missouri
$1.2K +$1.01K +129 New
IA
177
IFP Advisors
Florida
$1.01K – – –
AAP
178
Arax Advisory Partners
Colorado
$808 – – –
EWA
179
EverSource Wealth Advisors
Alabama
$724 +$313 +40 +105%
SAM
180
Smartleaf Asset Management
Massachusetts
$719 -$1.16K -148 -65%
SS
181
SBI Securities
Japan
$520 – – –
TCM
182
TD Capital Management
Tennessee
$436 – – –
EP
183
Essential Partners
California
$306 +$258 +33 New
LFG
184
Larson Financial Group
Missouri
$74 +$63 +8 New
TPWA
185
Twin Peaks Wealth Advisors
California
$25 +$16 +2 New
Federated Hermes
186
Federated Hermes
Pennsylvania
$19 – – –
PA
187
Perceptive Advisors
New York
– -$6.71M -915,775 Closed
SCM
188
Silverarc Capital Management
Massachusetts
– -$4.04M -551,570 Closed
First Trust Advisors
189
First Trust Advisors
Illinois
– -$1.6M -217,970 Closed
CSS
190
Cubist Systematic Strategies
Connecticut
– -$1.01M -137,871 Closed
SC
191
Stempoint Capital
New York
– -$913K -124,523 Closed
ECM
192
ExodusPoint Capital Management
New York
– -$705K -96,185 Closed
Canada Pension Plan Investment Board
193
Canada Pension Plan Investment Board
Ontario, Canada
– -$600K -81,800 Closed
Tudor Investment Corp
194
Tudor Investment Corp
Connecticut
– -$584K -79,648 Closed
CF
195
Corebridge Financial
Texas
– -$568K -77,460 Closed
Two Sigma Advisers
196
Two Sigma Advisers
New York
– -$536K -73,100 Closed
PAMP
197
Polar Asset Management Partners
Ontario, Canada
– -$415K -56,670 Closed
GCM
198
Graham Capital Management
Connecticut
– -$357K -48,749 Closed
WA
199
Waverly Advisors
Alabama
– -$350K -47,691 Closed
Voloridge Investment Management
200
Voloridge Investment Management
Florida
– -$333K -45,437 Closed
5 6 7
8
9

OCUL Hedge Fund Activity: Q2 2025 in Review

186 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Ocular Therapeutix (OCUL) for Q2 2025, worth a combined $1.45B — up 44% from $1.01B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of OCUL and 24 opened new positions — a net loss of 7 holders — while 48 trimmed existing stakes and 75 added.

The largest buyer was Fidelity Investments, adding an estimated $146M. The largest seller was BlackRock, cutting an estimated $11.5M.

  • 186 institutional investors held Ocular Therapeutix (OCUL) as of Q2 2025, down from 196 in Q1 2025.
  • Funds reported $1.45B of Ocular Therapeutix stock for Q2 2025, up 44% quarter-over-quarter.
  • 24 funds opened new Ocular Therapeutix positions in Q2 2025 and 31 closed out, a net change of -7 holders.
  • The largest Ocular Therapeutix buyer in Q2 2025 was Fidelity Investments, an estimated $146M added.
  • The largest Ocular Therapeutix seller in Q2 2025 was BlackRock, an estimated $11.5M sold.

Based on aggregated 13F filings for Q2 2025.